i2Contour
Overview
i2Contour is a web-based, AI-powered software platform developed by MRIMath. It is specifically designed to enhance the efficiency and precision of glioblastoma (GBM) management. The tool provides semi-automatic labeling, visualization, and volumetric quantification of WHO grade 4 glioblastoma from standard MRI images, including FLAIR and T1 contrast sequences. It combines advanced AI algorithms with a user-friendly interface, allowing trained medical professionals to review, manually contour, and approve tumor segmentations. The platform aims to significantly reduce the time required for GBM labeling and volume measurement, potentially saving physicians up to an hour per imaging study. By minimizing inter-user variability and improving precision, i2Contour supports better clinical decision-making, treatment planning, and monitoring of patient outcomes over time.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered GBM segmentation (FLAIR and T1 contrast sequences)
- Smart manual contouring to reduce inter-user variability
- Precise volume measurement and plotting for monitoring and treatment planning
- Time-saving efficiency (reduces labeling/measurement time by up to an hour)
- Secure cyber device compliant with FDA security measures
- Collaborative team spaces for workflow optimization
- DICOM viewer
- Web-based software platform
- Anonymization of patient data
- Sharing and exchange capabilities
Use Cases
- Glioblastoma (GBM) management
- Brain tumor segmentation and volumetric analysis
- Radiation therapy planning
- Monitoring treatment response over time for GBM
- Aiding clinical decision-making in neuro-oncology
- Collaborative review and approval processes for imaging studies
What Physicians Need to Know
Leverage i2Contour's FDA 510k-cleared AI for rapid and accurate GBM and metastatic brain tumor segmentation to enhance treatment decision-making and patient monitoring. Utilize the secure, cloud-based platform for collaborative research and consultations, and take advantage of the volumetric measurements for longitudinal tracking of disease progression or response to treatment. The smart manual contouring and AI-powered features can significantly reduce contouring time and inter-user variability.
The platform is cloud-based and designed for secure communication and data exchange, facilitating collaboration among healthcare professionals. It supports the download of segmentations and volumes, and offers registration, sharing, and anonymization features for seamless integration into existing clinical and research workflows.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Free Trial | Yes |
| Deployment | Cloud-based |
| Data Export | Yes |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurosurgery, Oncology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-08-08 | K233822 510(k) | i2Contour |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate i2Contour
Videos
Product demos, reviews, and walkthroughs for i2Contour.





